163 related articles for article (PubMed ID: 38353683)
21. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
Chew DS; Li Y; Zeitouni M; Whellan DJ; Kitzman D; Mentz RJ; Duncan P; Pastva AM; Reeves GR; Nelson MB; Chen H; Reed SD
JAMA Cardiol; 2022 Feb; 7(2):140-148. PubMed ID: 34817542
[TBL] [Abstract][Full Text] [Related]
22. Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.
Cowie MR; Thokala P; Ihara Z; Adamson PB; Angermann C
ESC Heart Fail; 2023 Oct; 10(5):3046-3054. PubMed ID: 37591524
[TBL] [Abstract][Full Text] [Related]
23. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
Gaziano TA; Fonarow GC; Claggett B; Chan WW; Deschaseaux-Voinet C; Turner SJ; Rouleau JL; Zile MR; McMurray JJ; Solomon SD
JAMA Cardiol; 2016 Sep; 1(6):666-72. PubMed ID: 27438344
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure.
Dang W; Yi A; Jhamnani S; Wang SY
Am J Cardiol; 2017 Oct; 120(8):1338-1343. PubMed ID: 28842145
[TBL] [Abstract][Full Text] [Related]
26. Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.
Moertl D; Steiner S; Coyle D; Berger R
Int J Technol Assess Health Care; 2013 Jan; 29(1):3-11. PubMed ID: 23257208
[TBL] [Abstract][Full Text] [Related]
27. Economic Evaluation of Telemedicine for Patients in ICUs.
Yoo BK; Kim M; Sasaki T; Melnikow J; Marcin JP
Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
Martinson M; Bharmi R; Dalal N; Abraham WT; Adamson PB
Eur J Heart Fail; 2017 May; 19(5):652-660. PubMed ID: 27647784
[TBL] [Abstract][Full Text] [Related]
29. A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program.
Murphy TM; Waterhouse DF; James S; Casey C; Fitzgerald E; O'Connell E; Watson C; Gallagher J; Ledwidge M; McDonald K
Int J Cardiol; 2017 Apr; 232():330-335. PubMed ID: 28087180
[TBL] [Abstract][Full Text] [Related]
30. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
Jiang X; Yao J; You JH
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
[TBL] [Abstract][Full Text] [Related]
31. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
[TBL] [Abstract][Full Text] [Related]
33. Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway.
Hansson-Hedblom A; Axelsson I; Jacobson L; Tedroff J; Borgström F
J Headache Pain; 2020 Aug; 21(1):99. PubMed ID: 32787820
[TBL] [Abstract][Full Text] [Related]
34. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation comparing intraoperative cone beam CT-based navigation and conventional fluoroscopy for the placement of spinal pedicle screws: a patient-level data cost-effectiveness analysis.
Dea N; Fisher CG; Batke J; Strelzow J; Mendelsohn D; Paquette SJ; Kwon BK; Boyd MD; Dvorak MF; Street JT
Spine J; 2016 Jan; 16(1):23-31. PubMed ID: 26456854
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
Cowie MR; Simon M; Klein L; Thokala P
Eur J Heart Fail; 2017 May; 19(5):661-669. PubMed ID: 28176424
[TBL] [Abstract][Full Text] [Related]
37. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
[TBL] [Abstract][Full Text] [Related]
38. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
